Podcasts about Retinal

Hearing the buzz around skin cycling? We have been too. This week, we're joined by Dr. Whitney Bowe as she breaks down the concept of skin cycling. Listen in as she discusses her treatment philosophy, what it means for skin routines to be "smarter not more," and offers valuable advice for curious dermatologists looking to challenge conventional wisdom. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Whitney Bowe, MD is a renowned, board-certified dermatologist and scientist based in New York. She is one of the most in-demand dermatologists in the country, in addition to being a founding member of the Dermstore Medical Advisory Board and a distinguished thought leader in the space. For the past seven years, her practice has been fully booked and capped, but now with her skin-care line, Dr. Whitney Bowe Beauty, you can bring the doctor home with you. Dr. Bowe championed a focus on the skin-gut-mind connection. Her “three-dimensional” approach to skincare—treating skin from both the outside and inside—challenged long-held beliefs within the field of dermatology. She is also responsible for bringing the viral skin-care concept of Skin Cycling to the world, which has amassed more than 3 billion TikTok views. With a deep knowledge of the skin, skin care products and dermatology, Dr. Bowe is constantly quoted in top media outlets like Vogue, The New York Times and Good Morning America. Enjoy 15% off your Dr. Whitney Bowe Beauty order at drwhitneybowebeauty.com with code LEARNSKIN15, valid April 3-17, 2025. Don't miss out!      

We love to hear from our listeners. Send us a message.In this episode of Cell & Gene: The Podcast, Host Erin Harris dives into the world of retinal gene therapy with Kenji Fujita, M.D., Chief Medical Officer of Atsena Therapeutics. Atsena develops treatments for inherited retinal diseases, including X-linked retinoschisis (XLRS), a rare genetic condition that currently has no FDA-approved therapy. They talk through the impact of XLRS on patients, the challenges of gene delivery to the retina, and how Atsena's AAV vector technology is designed to overcome these hurdles. They also discuss the significance of the Fast Track designation recently granted to Atsena's XLRS program, the role of patient advocacy in rare disease research, and the key milestones to watch for in the months ahead.Subscribe to the podcast!Apple | Spotify | YouTube

BUFFALO, NY — March 25, 2025 — A new #research paper was #published in Aging (Aging-US) on January 31, 2025, in Volume 17, Issue 2, titled “Cysteinyl leukotriene receptor 1 modulates retinal immune cells, vascularity and proteolytic activity in aged mice.” The study, led by first author and corresponding author Andreas Koller from the University Hospital of the Paracelsus Medical University, found that blocking an inflammatory receptor called CysLTR1 in the retinas of aging mice improved retinal health. These findings suggest a new approach to slowing age-related vision loss and protecting eye health in older adults. Age-related vision problems are a growing concern worldwide, and inflammation plays a key role in damaging the retina over time. The retina is the part of the eye that captures light and sends visual signals to the brain, making it vital for clear eyesight. In this study, scientists focused on the CysLTR1 receptor, which is known to promote inflammation and is found in high amounts in the retina. They explored whether blocking this receptor could reduce the harmful effects of aging in the eye. To achieve this, researchers treated aged mice with montelukast (MTK), a drug commonly used for asthma, which specifically blocks CysLTR1. The oral treatment lasted eight weeks and results were compared with both untreated aged mice and healthy young mice. After treatment, the older mice showed major improvements in retinal health. One key finding was a reduction in immune cells called microglia, which tend to increase with age and contribute to chronic inflammation in the retina. With CysLTR1 blocked, the number of these immune cells dropped significantly, suggesting reduced retinal inflammation. Lower inflammation is linked to a lower risk of age-related eye diseases like macular degeneration. “The reduction in immune cells caused by Cysltr1 suppression may dampen neuroinflammation, a known promoter of tissue aging.” Another important result was the restoration of blood vessel function. The tiny blood vessels in the retina had narrowed in aging mice, reducing blood flow and oxygen supply to the eye. MTK treatment increased the diameter of these vessels, improving circulation and possibly helping the retina work more efficiently. The study also indicated that blocking CysLTR1 helped boost the retina's natural ability to clear out waste proteins. As we age, this cleaning process slows down, allowing harmful material to build up in the eye. After treatment, the aged mice had stronger proteasome activity—the system responsible for breaking down cellular waste—and fewer signs of waste accumulation. Importantly, the treatment did not harm retinal nerve cells, which are essential for vision. This evidence indicates that the therapy was not only effective but also safe. While more research is needed to confirm these results in humans, this study highlights the potential of repurposing MTK to protect against age-related vision decline. Because it is already an approved drug, testing it for age-related eye diseases like macular degeneration or diabetic retinopathy could move forward more quickly. Blocking inflammation and supporting the eye's natural cleaning systems may be a promising new way to preserve healthy vision in aging populations. DOI - https://doi.org/10.18632/aging.206193 Corresponding author - Andreas Koller - a.koller@salk.at Video short - https://www.youtube.com/watch?v=ngnrPJzHlpI Please visit our website at https://www.Aging-US.com​​ and connect with us: Facebook - https://www.facebook.com/AgingUS/ X - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/@AgingJournal LinkedIn - https://www.linkedin.com/company/aging/ Pinterest - https://www.pinterest.com/AgingUS/ Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

Which of the two following findings would be anticipated in the normal fundoscopic exam of a healthy 40-year-old woman who is normotensive, generally in good health and without ocular complaint?  A. Arteriovenous nickingB. Optic cup to disc ratio < .0.5C. Retinal arteries are brighter and narrower than veins  D. Slight bulging of the optic diskVisit fhea.com to learn more!

Drs. Rebecca Soares, Akshay Thomas, and Sarwar Zahid join the podcast for a journal club discussion covering three recent articles in major ophthalmology journals.Macula-Off Retinal Detachment Prognostic Factors (https://journals.lww.com/retinajournal/abstract/9900/preoperative_and_early_postoperative_factors.944.aspx)Progression to PDR from NPDR after Cataract Surgery (https://www.aaojournal.org/article/S0161-6420(25)00125-3/abstract)Sexual Harassment in Ophthalmology (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2830480)Relevant Financial Disclosures: NoneYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

*This month in partnership with Choroideremia Research Foundation**Our Carrier Connections program features a different X-linked condition each month with the goal to increase awareness of X-linked conditions and how they impact the lives of women and girls.This month, we are featuring choroideremia (CHM). CHM is an X-linked disorder caused by mutations in the gene, CHM, which produces a protein that plays a critical role in the cell's ability to transport proteins and organelles within and outside of the cell. When this gene is dysfunctional, the cell can no longer support this protein escort ability, resulting in premature cell death primarily in the eyes. Typically, this condition is characterized by progressive vision loss. These symptoms may begin at any age, but tend to onset between childhood and adulthood. Females carriers of CHM have been proven to experience a spectrum of symptoms, ranging from mild to severe retinal degeneration. Today, we are featuring Dr. Sena Gocuk. Dr. Gocuk is an optometrist and postdoctoral research fellow specialising in inherited retinal diseases (IRD), with a particular focus on female carriers of X-linked IRDs. Her research explores the unique challenges female carriers face, from variability in disease expression to their underrepresentation in clinical trials. Dr. Gocuk has led innovative studies investigating retinal changes in female carriers, providing insights into emerging treatments such as gene therapy. She is an advocate for the inclusion of female carriers in research and treatment interventions, regularly sharing her findings to promote better care and access for this often-overlooked population.RESOURCES:Choroideremia Research FoundationRetinal Characteristics of Female Choroideremia Carriers: Multimodal Imaging, Microperimetry, and GeneticsLongitudinal assessment of female carriers of choroideremia using multimodal retinal imagingFemale carriers of X-linked inherited retinal diseases - Genetics, diagnosis, and potential therapiesCarrier Connections is sponsored by Kyowa Kirin and Amgen. For more information about our organization, check out ⁠⁠⁠⁠⁠⁠rememberthegirls.org⁠⁠⁠⁠⁠⁠.

Ogul Uner, MD, invites Scott Oliver, MD, to the podcast to review a case of a 60-year-old man who presented with new flashes, floaters, and blurriness in his inferior field of vision in his right eye. The patient is a high myope with a relative afferent pupillary defect and pigmented cells in the anterior vitreous, with OCT imaging showing a macula-off retinal detachment. Dr. Oliver shares his approach to this case, reviews risk factors for retinal detachments, and shares insights into treatment.

Drs. Katherine Talcott and Akshay Thomas join to discuss the March 2025 edition of Retinal Physician focusing on dry age-related macular degeneration, including photobiomodulation, complement inhibition, and deep learning for imaging.Relevant Financial Disclosures: Dr. Sridhar has consulted for Apellis.You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/DJG865. CME credit will be available until March 3, 2026.Retinal Disease in Emergency Medicine: Timely Recognition and Referral for Specialty CareThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Emergency Physicians and PVI, PeerView Institute for Medical Education. The American College of Emergency Physicians is accredited by the ACCME to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/DJG865. CME credit will be available until March 3, 2026.Retinal Disease in Emergency Medicine: Timely Recognition and Referral for Specialty CareThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Emergency Physicians and PVI, PeerView Institute for Medical Education. The American College of Emergency Physicians is accredited by the ACCME to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/DJG865. CME credit will be available until March 3, 2026.Retinal Disease in Emergency Medicine: Timely Recognition and Referral for Specialty CareThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Emergency Physicians and PVI, PeerView Institute for Medical Education. The American College of Emergency Physicians is accredited by the ACCME to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/DJG865. CME credit will be available until March 3, 2026.Retinal Disease in Emergency Medicine: Timely Recognition and Referral for Specialty CareThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Emergency Physicians and PVI, PeerView Institute for Medical Education. The American College of Emergency Physicians is accredited by the ACCME to provide continuing medical education for physicians.This activity is developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

#48. Oversiktsepisode om øyemanifestasjoner ved revmatisk sykdom. Del 2 av 2.Tredje sesong av podkasten er muliggjort gjennom et stipend fra Norsk revmatologisk forening. Hosted on Acast. See acast.com/privacy for more information.

انسداد شریان مرکزی شبکیه

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com Early detection of Alzheimer's disease is crucial, and accessible diagnostic tools like retinal imaging are becoming increasingly vital.  In this episode, Eliav Shaked, co-founder of RetiSpec, discusses their innovative approach to early and accurate Alzheimer's detection using retinal imaging and artificial intelligence. RetiSpec focuses on identifying the core pathology of Alzheimer's, specifically amyloid burden, through a simple eye examination that can be incorporated into annual checkups. The company is also working on other neurodegenerative diseases beyond Alzheimer's. Eliav emphasizes the significance of recent breakthroughs in Alzheimer's medication, highlighting the potential of disease-modifying drugs now available, along with the growing innovation and therapeutic development in the space. He also predicts that more drugs will be developed for earlier stages of the disease and that technology will revolutionize healthcare.  Tune in and learn how this innovative technology is paving the way for better Alzheimer's care! Resources:  Connect and follow Eliav Shaked on LinkedIn. Follow RetiSpec on LinkedIn and visit their website.  Fast Track Your Business Growth: Outcomes Rocket is a full-service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com

Marc R. Bloomenstein, OD, FAAO, invites Steven Ferrucci, OD, FAAO, to discuss the role of optometrists in diagnosing and referring patients with geographic atrophy, diabetic retinopathy, and other retinal conditions. They will also discuss the integration of artificial intelligence and at-home monitoring technology to help manage these patients.

Ja, som avsnittets namn avslöjar så kommer veckans avsnitt att fokusera på Retinol! Emma och Frida tar det hela ett steg längre och fördjupar sig i Retinol, Bakuchiol och Retinal. Vad är det ena, vad är det andra? Vem ska ha vad och när ska en ha det? Vad är det som är så speciellt med just dessa produkter och på vilket sätt påverkar de huden? Det blir tips på olika formulas och styrkor (såklart förklarar Frida och Emma vad poängen är med just “styrkor”), samt vid vilka tillfällen det kan vara en bra idé att ändra på produktens styrka. Det blir också tips på sprillans nya produkter som Frida och Emma känner har en it-faktor. Spänn fäst er och gör er redo för ett redigt Retinolspecial!Klipps av Gabriella Lahti. Hosted on Acast. See acast.com/privacy for more information.

Ja, som avsnittets namn avslöjar så kommer veckans avsnitt att fokusera på Retinol! Emma och Frida tar det hela ett steg längre och fördjupar sig i Retinol, Bakuchiol och Retinal. Vad är det ena, vad är det andra? Vem ska ha vad och när ska en ha det? Vad är det som är så speciellt med just dessa produkter och på vilket sätt påverkar de huden? Det blir tips på olika formulas och styrkor (såklart förklarar Frida och Emma vad poängen är med just “styrkor”), samt vid vilka tillfällen det kan vara en bra idé att ändra på produktens styrka. Det blir också tips på sprillans nya produkter som Frida och Emma känner har en it-faktor. Spänn fäst er och gör er redo för ett redigt Retinolspecial!Klipps av Gabriella Lahti. Hosted on Acast. See acast.com/privacy for more information.

How do couples navigate the tumultuous journey of unexpected medical crises? For Wayne and Ivanna, it began with Wayne's emergency retina surgery, quickly followed by Ivanna's shocking breast cancer diagnosis at age 33. They found solace and strength in each other, embracing health advocacy and community support. Through their ordeal, they transformed their challenges into a mission to inspire and educate others. Key Questions Answered 1. What health advocacy steps does Ivanna recommend for women? 2. How did Ivanna and Wayne handle the emotional and mental health aspects of dealing with illness? 3. How did Ivanna's initial breast cancer diagnosis occur, and what was her reaction? 4. What was Wayne's role and response in supporting Ivanna during her health challenges? 5. How did Ivanna and Wayne's health challenges affect their family plans and vacations? 6. What critical health decision did Ivanna make regarding her cancer treatment, and what was the outcome? 7. What was the significance of self-advocacy as highlighted by both Ivanna and the host Dorothy Gibbons? Timestamped Overview 00:00 Met beautiful woman while bartending one Sunday. 03:43 Date night mishap: fancy wine, no glassware. 08:17 Breast lump concerns repeatedly dismissed by doctors. 10:14 Got biopsy results earlier than expected. 13:10 Struggled with pregnancy and potential health issues. 16:29 Post-pregnancy breast changes important for diagnosis. 21:41 Seeking definitive guidance on radiation treatment necessity. 25:20 Concerned about children's fast-paced upbringing. 27:53 Vacation plan canceled due to emergency surgery. 29:49 Retinal detachment diagnosed; emergency surgery needed. 33:43 Not ready for breast cancer survivor group.See omnystudio.com/listener for privacy information.

Dr. Carlos Quezada-Ruiz is a Vitreoretinal Surgeon and Assistant Professor of Ophthalmology at the Instituto de Oftalmologia Fundación Conde de Valenciana's Retina Department in Mexico City. He also serves as the Senior Vice President of Clinical Research and Development and Therapeutic Area Head (Ophthalmology) at 4DMT, leading early- and late-stage clinical development teams focused on treating neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and geographic atrophy (GA). In addition to his active clinical practice, Dr. Quezada-Ruiz has spent the past decade as a Drug Developer, beginning at Genentech–Roche. There, he worked on the Ophthalmology management team as Group Medical Director of Clinical Science (Product Development). During his tenure, he led the design, execution, and analysis of U.S. and global registrational trials for multiple retinal diseases, including the nAMD global clinical development program for VABYSMO, resulting in U.S. and worldwide approvals. He also led the global clinical science team for SUSVIMO, supporting its initial global filing, FDA approval, and launch in nAMD; successfully navigated the U.S. voluntary recall and commercial relaunch; and oversaw the phase 3 DR/DME registrational program through execution, readout, and filing with the FDA in early 2024. Previously, Dr. Quezada-Ruiz led Medical Affairs efforts for the U.S. launch of Lucentis Prefilled Syringe (PFS) and the myopic choroidal neovascularization indication for LUCENTIS. Furthermore, Dr. Quezada-Ruiz contributed to diversity and inclusion strategies in the Ophthalmology Franchise—such as the AAO MOM program—and advanced personalized healthcare in retina at Genentech by helping design and develop predictive models that use machine learning and large language models to support both drug development and clinical practice. Dr. Quezada-Ruiz is a Fellow of the American Society of Retina Specialists, with over 13 years of clinical practice and research in vitreoretinal diseases and surgery. He earned his M.D. from Universidad Autónoma de Coahuila in his hometown of Torreón, Mexico. He completed fellowships in Vitreoretinal Surgery, Ocular Pathology Research, and Vitreoretinal Surgery Research at Universidad Nacional Autónoma de México, McGill University, and the California Retina Research Foundation, respectively. In 2023, he completed an Executive Education program (CIBE) at Columbia Business School. His accolades include the 2023 Roche Award of Excellence in recognition of outstanding contributions to Roche Pharmaceuticals (“Vabysmo and Beyond”), Genentech's 2023 Medical Excellence Award, the 2019 American Society of Retina Specialists Senior Honor Award, the 2016 ASRS Honor Award, the 2013 Gillingham Pan-American Fellowship by the Pan-American Association of Ophthalmology and The Retina Research Foundation of Houston, Texas, and the 2013 Leonard Ellen Ocular Pathology Award by the Royal Victoria Hospital Foundation. On a personal note, Dr. Quezada-Ruiz is married to Cecy—formerly a marketing specialist at The Coca-Cola Company—and they have three children and a white Labrador, Mia, who is blind from retinal dystrophy. He is also a retired martial artist, philosopher, and health enthusiast. About 4DMT 4DMT is a clinical-stage genetic medicines company focused on harnessing the full potential of genetic therapies for large market diseases, particularly in ophthalmology (wet AMD and DME) and pulmonology (cystic fibrosis lung disease). Therapeutic Vector Evolution (TVE): 4DMT's proprietary vector platform leverages the Nobel Prize–winning technology of directed evolution to create customized viral vectors. This approach propels a diverse product pipeline aimed at revolutionizing medicine with potentially curative therapies for millions of patients.  

Stress hormones are released immediately during challenging situations, making stress a significant yet subjective experience. These stress hormones increase insulin resistance & cause hyperglycemia unlike physical weight, stress cannot be quantified—it varies for everyone, making it a deeply personal phenomenon. Uncontrolled blood sugar can lead to complications like early-onset cataracts, often appearing as early as 45 or 50, especially in diabetics. Retinal issues and glaucoma are also common, emphasizing the need for annual eye exams. People with Diabetes should inform their doctors and prioritize regular evaluations to detect and manage potential eye complications effectively. Awareness promoted by the government and media highlights the importance of vaccinations. A disease Herpes zoster or shingles can affect individuals with diabetes. This virus resides in everyone but becomes active when the immune system weakens. Fortunately, a vaccine with 90% efficacy is available for those over 50. Administered in two doses, the first dose is followed by the second after two months, within a six-month window. Adult vaccination schedules should include common vaccines such as hepatitis B, pneumococcal, influenza, and herpes zoster. Evaluations for neuropathy (nerve damage) and vasculopathy (blood vessel damage) are also critical. Neuropathy affects nerves, while vasculopathy leads to arterial damage. Dr. Kavita Gupta advises caution during fasting, as starchy foods like potatoes and sabudana can spike blood sugar levels. Instead, opt for foods with a low glycemic index to avoid sugar surges. Increase fiber intake while avoiding sugar and jaggery. Common fasting foods like halwa, sago vada, and khichdi can elevate sugar levels. A better alternative is incorporating salads, roasted chickpeas, lemon water, small amounts of coconut water, or fresh coconut. Bhagar (a low glycemic index grain) combined with vegetables like tomatoes, peas, and carrots is beneficial. Including protein and lean meat can further improve dietary balance. Recorded on: 11.10.2024 Recorded at: Akashwani Nagpur

Imagine a future where a simple photo of your eye can detect chronic diseases like diabetes and heart conditions!  In this episode, Vicky Demas, CEO of identifeye HEALTH, shares how her company is using AI and automation to revolutionize diagnostic imaging. Discover how identifeye HEALTH is tackling workflow inefficiencies, improving access to care, and enabling early detection of chronic diseases like diabetes and cardiovascular conditions.  Tune in to explore the future of personalized medicine and patient-centered healthcare!

Drs. Safa Rahmani and Sarwar Zahid join the podcast to preview the January 2025 edition of Retinal Physician, found online at http://www.retinalphysician.com.Relevant Financial Disclosures: Dr. Sridhar has consulted for Genentech and Regeneron.You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Show Notes: Predictions • Both wars will run out of steam and end, officially or unofficially. • There will be insurrections in Iran. • Neither the Dodgers, nor the Celtics, nor the Chiefs will repeat. • Electric car requirements and limits on ICEs will be lifted or eased. • Retinal scanning and fingerprints will allow many to circumvent TSA. • Attempts to copyright and/or trademark AI composites of text and images will eventually reach the Supreme Court. • A betting scandal will rock professional sports. • As China's economy weakens it will engage in more limited military actions against Taiwan. • Universities will face a perfect storm: AI will enable cheating and plagiarism, students and parents will revolt against huge tuitions, government forgiveness of tuition debt will end, there will be attempts to fire tenured professors who teach radical and biased political views, and large cuts will have to be made. The biggest threat: Remote learning which will dramatically lower tuition and enable a greater choice of institutions. • As the population ages and the Millennials rise in business, the country becomes more conservative and centrist in its views and voting. • There will be more intensive recruiting and higher pay for police officers. • Two more members of Congress will be indicted for corruption. • The Taylor Swift phenomenon will begin to wane. • The largest contribution to population growth in the US will be from legal immigrants. • Hacking will accelerate, and will include all kinds of organizations. The government will grant immunity to convicted hackers to help them combat other hackers. • The smart Democrats will realize that it wasn't that “their message didn't get out,” but rather that most people didn't like the message. • Not a prediction, but a wish: Term limits for all of Congress so we can finally end the incestuous power grabbing that has undermined progress for the people. • Happy New Year.

Dr. NJ Manoharan joins the podcast to discuss working in a county hospital system as a retinal surgeon.Relevant Financial Disclosures: NoneYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

How many real-world patients with proliferative DR were concordant with the treatment directions in Protocol S? Adrienne Scott, MD, explains how a database review of real-world patients with proliferative DR revealed how few patients are concordant with the strict dosing schedule of Protocol S, and shares which baseline factors were linked to lack of concordance. And Dilraj Grewal, MD, provides an update on the relationship between retinal imaging and detection of Alzheimer disease. Just how close are we from using noninvasive retinal imaging techniques to screen for potential neurodegenerative conditions?

Retinal neurons derived from human stem cells are a promising source of replacement cells for regenerating damaged or diseased retinas. As scientists progress toward translation of cell therapies for restoring vision, they encounter challenges, including how to deliver the cells, ensure that they integrate appropriately with host tissue, and enable proper function after transplantation. In this episode, Iris Kulbatski from The Scientist spoke with Deepak Lamba, a distinguished scientist in the department of immunology and regenerative medicine at Genentech and an associate adjunct professor at the University of California, San Francisco, to learn more about how advances in cell culture models and associated technologies help researchers progress towards retinal cell therapy. The Scientist Speaks is a podcast produced by The Scientist's Creative Services Team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research. This month's episode is sponsored by Bio-Rad.

Professor Maher Saleh discusses his group's findings for the use of perfluorocarbon in the treatment of macula-off retinal detachment. The study results suggest that perfluorocarbon liquid use during vitrectomy for macula-Off Retinal detachment has no impact on Macular folds and Metamorphopsia. Discussed article:  Wurtz M, Dormegny L, Muller C, Bourcier T, Ballonzoli L, Gaucher D, Saleh M. PERFLUOROCARBON LIQUID USE DURING VITRECTOMY FOR MACULA-OFF RETINAL DETACHMENT HAS NO IMPACT ON MACULAR FOLDS AND METAMORPHOPSIA. Retina. 2024 Nov 1;44(11):1891-1898. doi: 10.1097/IAE.0000000000004220. PMID: 39102743.

Drs. Avni Finn and Sarwar Zahid join the podcast to preview the November 2024 edition of Retinal Physician, found online at http://www.retinalphysician.com.Relevant Financial Disclosures: NoneYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

On today's episode I am speaking with Nicolas Travis, the founder of Allies of Skin. Backed by his degree in biomedical and pharmaceutical science, but also personal life events – Nicolas gets vulnerable about what drove him to create a brand that would improve people's confidence and skincare with purpose and real results. We dive into which products you need to be using, retinol vs retinal, what peptides actually do, skincare myths, and so much more. Tune in for an incredibly inspiring founder story and key tips and tricks for your skincare routine! Enjoy!To connect with Nicolas on Instagram, click HERE.To shop Allies of Skin, click HERE.To connect with Siff on Instagram, click HERE.To connect with Siff on Tiktok, click HERE.To learn more about Arrae, click HERE. To check out Siff's LTK, click HERE.To check out Siff's Amazon StoreFront, click HERE. This episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct, or indirect financial interest in products, or services referred to in this episode.Produced by Dear MediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Are retina doctors seeing more retinal pathology following infection or vaccination? Or is there nothing to see here? Rahul Khurana, MD, joins us to discuss the findings of various health care database analyses seeking to clarify whether COVID infection or vaccination were linked to retinal manifestations. Was there a clear—or even an opaque—connection between the two? And Paul Hahn, MD, PhD, sits down with us to explain how inflation, new realities of reimbursement, and step therapy directives are playing out in retina clinics in the United States. Inflation-adjusted reimbursement is declining—but can anything be done about it? And is step therapy actually saving the system any cash? 

Dr. Vicky Demas, CEO of identifeye HEALTH, is using AI-powered diagnostic algorithms and automation to improve the accessibility and quality of retinal imaging, focusing on the early detection of diabetic retinopathy. The identifeye technology makes it easier for patients to get screened for eye conditions in primary care or retail settings. The goal is to leverage the information from retinal scans to detect other eye conditions and identify biomarkers for other systematic diseases.   Vicky explains, "In general, we leverage AI and automation to solve workflow problems to make, first and foremost the capturing of good-quality retinal imaging. It's really easy to make sure that, for example, we can remove the barriers and access for that. We don't need to be at a specialist office for a lot of the screening conditions. Very specifically too, for our first application, we're focusing on diabetic retinopathy, which is a huge problem and one where accessibility to good quality screenings and early detection or early detection is a huge problem that we're hoping to help with." "What it comes to is not about the camera or the resolution. Still, it is really about making sure that the capturing is of good quality, high quality. I'll call it an image that can be analyzed and interpreted. It can be done with someone with very little training upfront. Also, the information that you have to retain to run an exam is low. So, if you didn't run the device and are not operating it routinely, you don't have to remember what menu I opened and where the data is. And now I'm going to go and open this. We have used consumer product development principles to bring in usability and intuitive design, and of course, all powered by AI to automate all of that work." #identifeyeHEALTH #HealthcareInnovation #DigitalHealth #PrecisionMedicine #DiabeticRetinopathy #VisionHealth #Biomarkers identifeye.health  Listen to the podcast here

Dr. Vicky Demas, CEO of identifeye HEALTH, is using AI-powered diagnostic algorithms and automation to improve the accessibility and quality of retinal imaging, focusing on the early detection of diabetic retinopathy. The identifeye technology makes it easier for patients to get screened for eye conditions in primary care or retail settings. The goal is to leverage the information from retinal scans to detect other eye conditions and identify biomarkers for other systematic diseases.   Vicky explains, "In general, we leverage AI and automation to solve workflow problems to make, first and foremost the capturing of good-quality retinal imaging. It's really easy to make sure that, for example, we can remove the barriers and access for that. We don't need to be at a specialist office for a lot of the screening conditions. Very specifically too, for our first application, we're focusing on diabetic retinopathy, which is a huge problem and one where accessibility to good quality screenings and early detection or early detection is a huge problem that we're hoping to help with." "What it comes to is not about the camera or the resolution. Still, it is really about making sure that the capturing is of good quality, high quality. I'll call it an image that can be analyzed and interpreted. It can be done with someone with very little training upfront. Also, the information that you have to retain to run an exam is low. So, if you didn't run the device and are not operating it routinely, you don't have to remember what menu I opened and where the data is. And now I'm going to go and open this. We have used consumer product development principles to bring in usability and intuitive design, and of course, all powered by AI to automate all of that work." #identifeyeHEALTH #HealthcareInnovation #DigitalHealth #PrecisionMedicine #DiabeticRetinopathy #VisionHealth #Biomarkers identifeye.health  Download the transcript here

Live Nursing Review with Regina MSN, RN! Every Monday & Wednesday we are live. LIKE, FOLLOW, & SUB @ReMarNurse for more.     ► NCLEX Scary Topic - https://ReMarNurse.com/scary ► NCLEX V2 - https://study.remarnurse.com/vit/ ► Get Quick Facts Next Gen - https://bit.ly/QF-NGN ► Subscribe Now - http://bit.ly/ReMar-Subscription ► GET THE PODCAST: https://remarnurse.podbean.com/ ► WATCH LESSONS: http://bit.ly/ReMarNCLEXLectures/ ► FOLLOW ReMar on Instagram: https://www.instagram.com/ReMarNurse/ ► LIKE ReMar on Facebook: https://www.facebook.com/ReMarReview/   Quick Facts for NCLEX Next Gen Study Guide here - https://bit.ly/QF-NGN Study with Professor Regina MSN, RN every Monday as you prepare for NCLEX Next Gen.   ReMar Review features weekly NCLEX review questions and lectures from Regina M. Callion MSN, RN. ReMar is the #1 content-based NCLEX review and has helped thousands of repeat testers pass NCLEX with a 99.2% student success rate! ReMar focuses on 100% core nursing content and as a result, has the best review to help nursing students to pass boards - fast!

Dr. Rani Banik dives into the complexities of retinal strokes, specifically central retinal artery occlusion (CRAO), a vision-threatening condition often referred to as an “eye stroke.” Joined by esteemed retina specialist Dr. Richard Rosen, who brings decades of expertise and cutting-edge insights into retinal care, the episode explores the latest treatment advancements that are transforming […]

J. Daniel Diaz, MD, and Diana Shechtman, OD, FAAO, work side by side at Retinal Consultants of Miami. In this episode, Dr. Allen interviews them both to learn how they work together to serve their patients. Dr. Diaz and Dr. Shechtman agree that success starts with mutual respect and trust in each other and feel that collaborative care is the only way forward. Listen in as they discuss their backgrounds and the patient population they serve. They also share their thoughts on how other optometrists and ophthalmologists can collaborate to better serve their patients.  Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.

Welcome to another episode of Category Visionaries — the show that explores GTM stories from tech's most innovative B2B founders. In today's episode, we're speaking with Vicky Demas, CEO of Identifeye Health, a retinal imaging platform that has raised over $90 Million in funding. Here are the most interesting points from our conversation: Automating Retinal Imaging: Vicky explains how Identifeye Health is leveraging AI and automation to build a fully automated camera, simplifying retinal screening and addressing access to care. Founding Journey: The company received initial funding three and a half years ago, with Vicky brought in to reset the company's vision and direction, thanks to her expertise in AI-driven healthcare solutions from her time at Google X. Google X Experience: Vicky shares insights into her time at Google X, where the team worked on high-impact healthcare projects using AI, including early work on retinal imaging for diabetic retinopathy. Rebranding Challenge: Identifeye Health underwent a major rebranding exercise, turning it into an exciting team-driven initiative that created a more accurate and trademarkable brand name. Tackling Diabetic Retinopathy: Identifeye Health is focused on improving the accessibility and accuracy of diabetic retinopathy screening, aiming to solve the issue of low patient screening compliance with AI-driven simplicity. Pre-Commercial Stage: The company is in the final stages of commercialization, actively preparing manufacturing and quality management processes to launch their solution.   //   Sponsors: Front Lines — We help B2B tech companies launch, manage, and grow podcasts that drive demand, awareness, and thought leadership. www.FrontLines.io The Global Talent Co. — We help tech startups find, vet, hire, pay, and retain amazing marketing talent that costs 50-70% less than the US & Europe.  www.GlobalTalent.co  

Drs. Safa Rahmani and Katherine Talcott join the podcast to preview the October 2024 edition of Retinal Physician, found online at http://www.retinalphysician.com. The theme for this issue was clinical trials and anti-VEGF therapy.Relevant Financial Disclosures: Dr. Sridhar has consulted for Eyepoint, Genentech, and Regeneron.You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

In this episode, we sit down with Catherine Bornbaum, PhD, MBA, Chief Business Officer at RetiSpec, an AI company that uses fundus photography to detect Alzheimer's disease risk and development. Key Takeaways:RetiSpec's technology works with most standard fundus cameras and uses AI to assess and detect the retinal changes associated with amyloid deposition - the biggest risk factor and key diagnostic criteria for Alzheimer's.There are 55 million individuals globally living with dementia and there are at least 6.7 million individuals in the United States 65yo+ with dementia. It is believed these numbers vastly underestimate the number of individuals that have it. It is estimated that 1 out of 9 individuals age 65 and over have Alzheimer's disease.Having the conversation with those that are high risk or have early disease can be a challenge. Leverage the data from the report, lead with empathy, and own your role as part of the team - refer the patient to PCP or neurology for further workup and share more tests will be done to determine.There are two FDA approved medications for Alzheimer's disease and we know prevention is also key: diet, weight control, and exercise.Technologies like these will only advance the role optometrists play in full body health and wellness. Practices wanting to be successful in the future must take advantage of them. What Catherine is reading:Build: An Unorthodox Guide to Making Things Worth Making by Tony Fadell Practice Advantage Reading List** Don't miss out on an extra $10 rebate for all commercial VSP Eye Exams this year! Earn up to an additional $55,000 in 2024 AND 2025 just by taking great care of patients. Visit www.pecaaexamrebate.com now!**

Welcome to Episode 38 of “The 2 View,” the podcast for EM and urgent care nurse practitioners and physician assistants! Show Notes for Episode 38 of “The 2 View” – Retinal Artery Occlusion, Femoral Artery, and a guest appearance by Carl Lange, PA. Segment 1 Yaghoubi G.H., Heidari B. and B. Heidari. Case report: Central retinal artery occlusion in a 28-year-old man after 10 days of smoking cessation. World Health Organization - Regional Office for the Eastern Mediterranean. Accessed September 20, 2024. https://www.emro.who.int/emhj-volume-14-2008/volume-14-issue-5/case-report-central-retinal-artery-occlusion-in-a-28-year-old-man-after-10-days-of-smoking-cessation.html Segment 2 Howden W. Femoral artery. Radiopaedia.org. Revised March 24, 2023. Accessed September 20, 2024. https://radiopaedia.org/articles/femoral-artery?lang=us Ultrasound – Doppler Pseudoaneurysm Evaluation. UT southwestern department of radiology. Utsouthwestern.edu. Revised October 2, 2018. Accessed September 20, 2024. https://www.utsouthwestern.edu/education/medical-school/departments/radiology/protocols/assets/US%20Pseudoaneurysm.pdf Webb S, Madia C. Postcatheterization Femoral Pseudoaneurysms. American College of Cardiology. Published June 4, 2019. Accessed September 20, 2024. https://www.acc.org/Latest-in-Cardiology/ten-points-to-remember/2019/06/04/10/26/Postcatheterization-Femoral-Pseudoaneurysms Zeman J, Kompella R, Lee J, Kim AS. Case report: Non-thrombotic iliac vein lesion: an unusual cause of unilateral leg swelling in a patient with endometrial carcinoma. Front Cardiovasc Med. PMC PubMed Central. Published online May 2, 2023. Accessed September 20, 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185828/ Segment 3 California Board of Registered Nursing. Recruiting Expert Practice Consultants. Rn.ca.gov. Accessed September 20, 2024. https://www.rn.ca.gov/enforcement/expwit.shtml The Academy of Physician Associates in Legal Medicine. APALM. Published March 5, 2024. Updated June 7, 2024. Accessed September 20, 2024. https://www.apalm.net/ Recurring Sources Center for Medical Education. Ccme.org. http://ccme.org The Proceduralist. Theproceduralist.org. http://www.theproceduralist.org The Procedural Pause. Emergency Medicine News. Lww.com. https://journals.lww.com/em-news/blog/theproceduralpause/pages/default.aspx The Skeptics Guide to Emergency Medicine. Thesgem.com. http://www.thesgem.com Trivia Question: Send answers to 2viewcast@gmail.com Be sure to keep tuning in for more great prizes and fun trivia questions! Once you hear the question, please email us your guesses at 2viewcast@gmail.com and tell us who you want to give a shout-out to. Be sure to listen in and see what we have to share! Don't miss our upcoming EM Boot Camp this December in Las Vegas: https://courses.ccme.org/course/embootcamp/about

Michelle Holmes, OD, is a full-scope optometrist at the Pacific Neuroscience Institute®. She sees patients at both the Eye, Ear and Skull Base Center as well as at the Brain Health Center. She is board certified and TLG licensed to treat and manage ocular disease. She prides herself in practicing evidence-based medicine with a genuine enthusiasm for human connection.

Dr. Edward Legodi from South Africa joins the podcast to discuss his educational path, current challenges with providing retina care in Africa, and improving diversity of surgeons in Africa.Relevant Financial Disclosures: NoneYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Drs. Safa Rahmani and Kat Talcott join to discuss four recent major ophthalmology papers.Culture or No Culture for Endophthalmitis (https://ophthalmologyretina.org/article/S2468-6530(24)00338-5/abstract)Risk of Retinal Tear after Cataract Surgery (https://www.aaojournal.org/article/S0161-6420(24)00392-0/abstract)AREDS2 and GA Progression (https://www.aaojournal.org/article/S0161-6420(24)00425-1/abstract)Resident Salary and Benefits (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2820695#google_vignette)Relevant Financial Disclosures: Dr. Sridhar and Dr. Talcott have consulted for Apellis and Iveric.You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Drs. Maura Di Nicola and Basil Williams join to preview the September 2024 edition of Retinal Physician, found online at http://www.retinalphysician.com. The theme for this issue was ocular oncology.Relevant Financial Disclosures: NoneYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Buck shares his recent experience with a retinal tear and detachment, emphasizing the importance of early diagnosis and treatment to prevent permanent vision loss. He explains the anatomy of the eye, the process of vitreous detachment, and the symptoms of retinal tear and detachment. Buck also discusses the risk factors for these conditions, including high myopia and previous eye surgery. He describes his surgical experience and the use of a gas bubble to reattach the retina. 

Buck shares his experience with a retinal tear and detachment and how it reinforced the importance of gratitude and perspective. He discusses the psychological benefits of gratitude, including improved mental health, enhanced resilience, and stronger relationships. Buck suggests practices such as gratitude journaling, mindful appreciation, expressing thanks, and reframing challenges to cultivate gratitude. He emphasizes […] The post Gratitudes from a Retinal Tear appeared first on Wealth Formula.